IOL Chemicals and Pharmaceuticals Limited - Laporan Laba Rugi (TTM)

IOL Chemicals and Pharmaceuticals Limited
IN ˙ BSE
₹ 66.70 ↑1.28 (1.96%)
2025-04-29
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi IOL Chemicals and Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 19,463 19,481 19,670 20,254 20,298 20,719 21,840 22,305 22,340 22,024 22,171 22,153 22,192 22,161 21,328 20,720 20,524 20,554 20,792 21,285
Change (%) 0.09 0.97 2.97 0.22 2.08 5.41 2.13 0.16 -1.42 0.67 -0.08 0.18 -0.14 -3.76 -2.85 -0.94 0.14 1.16 2.37
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 10,793 10,763 11,096 11,897 13,116 14,263 15,812 16,407 16,378 16,088 15,605 15,310 14,817 14,655 14,041 13,899 13,920 13,901 14,013 14,291
Change (%) -0.27 3.09 7.21 10.25 8.74 10.86 3.76 -0.18 -1.77 -3.00 -1.90 -3.22 -1.09 -4.20 -1.01 0.15 -0.14 0.80 1.99
% of Revenue 55.45 55.25 56.41 58.74 64.62 68.84 72.40 73.56 73.31 73.05 70.39 69.11 66.77 66.13 65.83 67.08 67.82 67.63 67.39 67.14
Gross Operating Profit 8,670 8,717 8,573 8,357 7,182 6,456 6,028 5,898 5,963 5,935 6,566 6,843 7,375 7,505 7,287 6,821 6,604 6,652 6,779 6,994
Change (%) 0.54 -1.65 -2.52 -14.07 -10.10 -6.63 -2.15 1.10 -0.46 10.62 4.23 7.76 1.77 -2.91 -6.40 -3.18 0.73 1.91 3.16
% of Revenue 44.55 44.75 43.59 41.26 35.38 31.16 27.60 26.44 26.69 26.95 29.61 30.89 33.23 33.87 34.17 32.92 32.18 32.37 32.61 32.86
SG&A 1,062 1,104 1,157 1,251 1,280 1,350 1,415 1,518 1,567 1,633 1,686 1,787 1,873 1,938 2,027 2,017 2,114 2,155 2,183 2,229
Change (%) 3.93 4.84 8.11 2.34 5.48 4.83 7.22 3.24 4.21 3.26 5.97 4.85 3.44 4.62 -0.51 4.81 1.96 1.29 2.11
% of Revenue 5.46 5.66 5.88 6.18 6.31 6.52 6.48 6.80 7.01 7.41 7.60 8.07 8.44 8.74 9.51 9.73 10.30 10.49 10.50 10.47
R&D
Change (%)
% of Revenue
OpEx 13,638 13,688 14,139 15,154 16,483 17,896 19,679 20,694 20,854 20,708 20,370 20,219 19,979 19,977 19,651 19,280 19,334 19,361 19,489 19,902
Change (%) 0.37 3.29 7.18 8.77 8.57 9.96 5.16 0.77 -0.70 -1.63 -0.74 -1.19 -0.01 -1.63 -1.88 0.28 0.14 0.66 2.12
% of Revenue 70.07 70.27 71.88 74.82 81.21 86.38 90.10 92.78 93.34 94.03 91.88 91.27 90.03 90.15 92.14 93.05 94.20 94.20 93.73 93.50
Operating Income 5,825 5,792 5,531 5,100 3,815 2,823 2,161 1,611 1,487 1,315 1,801 1,934 2,213 2,184 1,677 1,439 1,191 1,192 1,303 1,384
Change (%) -0.56 -4.51 -7.79 -25.20 -26.01 -23.43 -25.46 -7.71 -11.53 36.92 7.36 14.44 -1.32 -23.19 -14.18 -17.28 0.15 9.27 6.20
% of Revenue 29.93 29.73 28.12 25.18 18.79 13.62 9.90 7.22 6.66 5.97 8.12 8.73 9.97 9.85 7.86 6.95 5.80 5.80 6.27 6.50
Interest Expense -45 -22 -9 -58 -17 -25 -24 -40 -57 -81 -107 -113 -122 -118 -108 -90 -87 -89 -99 -120
Change (%) -50.77 -57.85 514.89 -71.11 49.70 -2.80 66.26 40.10 42.58 32.47 5.33 8.26 -3.28 -8.06 -16.61 -3.54 1.83 11.49 21.01
% of Revenue -0.23 -0.11 -0.05 -0.29 -0.08 -0.12 -0.11 -0.18 -0.25 -0.37 -0.48 -0.51 -0.55 -0.53 -0.51 -0.44 -0.42 -0.43 -0.48 -0.56
Net Income 4,428 4,596 4,446 3,840 2,879 2,132 1,677 1,353 1,204 1,041 1,391 1,503 1,723 1,716 1,344 1,185 998 973 1,011 1,050
Change (%) 3.79 -3.27 -13.62 -25.03 -25.96 -21.34 -19.28 -11.03 -13.52 33.62 8.04 14.61 -0.41 -21.66 -11.82 -15.79 -2.55 3.91 3.92
% of Revenue 22.75 23.59 22.60 18.96 14.18 10.29 7.68 6.07 5.39 4.73 6.28 6.79 7.76 7.74 6.30 5.72 4.86 4.73 4.86 4.93

Source: Capital IQ

Other Listings
IN:IOLCP ₹ 96.93
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista